MRI-negative myelitis associated with MOG-IgG antibody: A case report and literature reviews

Sechi, 2021, Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies, Mult. Scler., 27, 303, 10.1177/1352458520907900 Banwell, 2023, Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria, Lancet Neurol., 22, 268, 10.1016/S1474-4422(22)00431-8 Macaron, 2020, MOG-related disorders: a new cause of imaging-negative myelitis?, Mult. Scler., 26, 511, 10.1177/1352458519840746 Perez, 2019, MRI-negative myelitis associated with myelin oligodendrocyte glycoprotein antibody spectrum demyelinating disease, Child Neurol. Open, 6, 10.1177/2329048X19830475 Hwangbo, 2023, A case of MRI-negative encephalomyelitis in a patient with long-term stable myelin oligodendrocyte glycoprotein antibody-associated disease, J. Clin. Neurol., 19, 422, 10.3988/jcn.2022.0433 Kolcava, 2022, Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report, BMC Neurol., 22, 313, 10.1186/s12883-022-02837-5 Dale, 2014, Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton, Neurol. Neuroimmunol. Neuroinflamm., 1, 10.1212/NXI.0000000000000012 Murphy, 2022, Identification of specific causes of myelopathy in a large cohort of patients initially diagnosed with transverse myelitis, J. Neurol. Sci., 442, 120425, 10.1016/j.jns.2022.120425 Cacciaguerra, 2022, Neuroimaging features in inflammatory myelopathies: a review, Front. Neurol., 13, 993645, 10.3389/fneur.2022.993645 Takewaki, 2018, Normal brain imaging accompanies neuroimmunologically justified, autoimmune encephalomyelitis, Neurol. Neuroimmunol. Neuroinflamm., 5, 10.1212/NXI.0000000000000456 Marcucci, 2021, Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: a new mimicker of progressive multiple sclerosis?, Mult. Scler. Relat. Disord., 52, 102964, 10.1016/j.msard.2021.102964 Rinaldi, 2021, the Australian and New Zealand MOG Study Group, Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders, Neurol. Neuroimmunol. Neuroinflamm., 8, e924, 10.1212/NXI.0000000000000924